KSNM60 in Non-thyroidal Radionuclide Therapy: Leaping into the Future
Author:
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging
Link
https://link.springer.com/content/pdf/10.1007/s13139-021-00703-9.pdf
Reference44 articles.
1. Kang HJ, Lee SS, Kim KM, Choi TH, Cheon GJ, Kim WS, et al. Radioimmunotherapy with 131I-rituximab for patients with relapsed/refractory B-cell non-Hodgkin’s lymphoma(NHL). Asia Pac J Clin Oncol. 2011;7:136–45.
2. Lee I, Byun BH, Lim I, Kim BI, Choi CW, Kim KM, et al. Comparisons of 131I-rituximab treatment responses in patients with aggressive lymphoma and indolent lymphoma. Ann Nucl Med. 2019;33:881–90.
3. Kang HJ, Lee SS, Byun BH, Kim KM, Lim I, Choi CW, et al. Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma. Cancer Chemother Pharmacol. 2013;71:945–53.
4. Shin DY, Byun BH, Kim KM, Kang JH, Lim I, Kim BI, et al. Radioimmunotherapy with 131I-rituximab as consolidation therapy for patients with diffuse large B-cell lymphoma. Cancer Chemother Pharmacol. 2016;78:825–31.
5. Seelam SR, Banka VK, Lee YS, Jeong JM. 188Re Labeled liver therapeutic drugs for hepatic carcinoma (HCC). J Radiopharm Mol Probes. 2019;5:26–35.
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in Radionuclides and Radiolabelled Peptides for Cancer Therapeutics;Pharmaceutics;2023-03-17
2. Radiolabeled nanoporous hydroxyapatite microspheres: An advanced material for potential use in radiation synovectomy;Materials Chemistry and Physics;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3